Orca Biosystems, Inc.
Clinical trials sponsored by Orca Biosystems, Inc., explained in plain language.
-
Engineered stem cell graft aims to improve transplant success in blood cancers
Disease control Recruiting nowThis early-phase study tests a new way to prepare donor stem cells (called Orca-Q) for transplant in people with certain blood cancers like leukemia. The goal is to see if this engineered graft is safe and helps the body accept the new cells without serious side effects. About 30…
Phase: PHASE1 • Sponsor: Orca Biosystems, Inc. • Aim: Disease control
Last updated May 17, 2026 01:29 UTC
-
New cell therapy aims to improve stem cell transplant outcomes for blood cancer patients
Disease control Recruiting nowThis study tests a personalized cell therapy called Orca-T for 80 adults with acute myeloid leukemia or myelodysplastic syndrome. Participants receive a stem cell transplant with specially processed donor cells designed to reduce complications like graft-versus-host disease. The …
Phase: PHASE2 • Sponsor: Orca Biosystems, Inc. • Aim: Disease control
Last updated May 11, 2026 20:38 UTC